TrumpRx is a discount prescription program that aims to reduce out-of-pocket costs for medications, including GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound. It works by connecting members with participating pharmacies and negotiated pricing, but it is not an insurance plan, a telehealth prescribing service, or a manufacturer savings program. Understanding exactly what it does — and does not — do is critical before you rely on it for a high-cost GLP-1 therapy.

What Is TrumpRx and How Does It Differ From Insurance?

TrumpRx is a prescription discount card or membership program, similar in structure to GoodRx or RxSaver. When you present a TrumpRx card or membership ID at a participating pharmacy, the pharmacy applies a pre-negotiated group rate rather than the pharmacy's standard retail price. The key distinctions are:

  • Not insurance: TrumpRx does not pay claims, meet deductibles, or count toward your out-of-pocket maximum under any health plan.
  • Not a prescriber: TrumpRx cannot write or authorize a GLP-1 prescription. You still need a licensed clinician to prescribe semaglutide or tirzepatide.
  • Not a manufacturer program: It is separate from Novo Nordisk's NovoCare savings card and Eli Lilly's LillyDirect program.
  • Pharmacy-dependent: Discounts apply only at pharmacies in the TrumpRx network; prices vary by location.

Most important: A discount card like TrumpRx does not replace a valid prescription. GLP-1 medications — Ozempic, Wegovy, Mounjaro, and Zepbound — are FDA-approved prescription drugs and legally require an order from a licensed prescriber before any pharmacy can dispense them.

Which GLP-1 Medications Can TrumpRx Be Used For?

In principle, TrumpRx can be presented for any FDA-approved GLP-1 or GIP/GLP-1 receptor agonist that a participating pharmacy stocks. The four most commonly sought drugs are:

  • Ozempic (semaglutide 0.5 mg, 1 mg, 2 mg): FDA-approved for type 2 diabetes management per the 2023 Ozempic prescribing information.
  • Wegovy (semaglutide 2.4 mg): FDA-approved for chronic weight management per the 2023 Wegovy prescribing information.
  • Mounjaro (tirzepatide 2.5–15 mg): FDA-approved for type 2 diabetes per the 2023 Mounjaro prescribing information.
  • Zepbound (tirzepatide 2.5–15 mg): FDA-approved for chronic weight management per the 2023 Zepbound prescribing information.

Because GLP-1 drugs carry list prices ranging from roughly $900 to over $1,300 per month without coverage, even a modest percentage discount can represent meaningful savings. However, actual savings through any discount card depend on the specific pharmacy's contracted rate, your dose, and local market pricing.

What Does the Step-by-Step Process Look Like?

Using TrumpRx for a GLP-1 medication typically follows this sequence:

  1. Get a prescription: Visit your primary care physician, endocrinologist, or a telehealth prescribing service. The prescriber determines whether a GLP-1 is medically appropriate for you.
  2. Enroll or obtain your TrumpRx card/ID: Sign up through the TrumpRx program website or obtain a physical card. Enrollment requirements and any membership fees vary.
  3. Search for a participating pharmacy: Use the TrumpRx pharmacy locator to find a network pharmacy near you that carries your specific medication and dose.
  4. Present your ID at the pharmacy: Show the pharmacist your TrumpRx card or membership number when dropping off or picking up your prescription.
  5. Pay the discounted price: You pay the negotiated out-of-pocket rate directly to the pharmacy.
  6. Compare alternatives before paying: It is always reasonable to compare the TrumpRx price against manufacturer savings programs and other discount cards on the same day, as prices fluctuate.

How Does TrumpRx Pricing Compare to Other Savings Options?

Before committing to any single savings route, consider the full landscape of options for GLP-1 costs:

Savings Option Who Qualifies Potential Monthly Cost
Insurance (commercial) Insured patients with formulary coverage $0–$300+ (copay/coinsurance)
Novo Nordisk NovoCare Card Commercially insured, eligible patients As low as $25/month (program limits apply)
Eli Lilly LillyDirect Savings Commercially insured, eligible patients As low as $25/month (program limits apply)
Discount cards (GoodRx, TrumpRx, etc.) Anyone; cannot combine with insurance Varies; often $800–$1,200+/month for GLP-1s
Compounded semaglutide/tirzepatide Anyone with a valid prescription $100–$400/month (not FDA-approved finished product)

Note: Compounded versions are not FDA-approved finished drug products. The FDA has stated that compounded semaglutide and tirzepatide remain on and off shortage lists, affecting legal availability. Always verify current FDA shortage status before pursuing compounded alternatives.

What Are the Limitations and Risks to Know?

Discount programs like TrumpRx are legitimate tools, but they come with real limitations when applied to expensive GLP-1 medications:

  • Supply shortages: Ozempic, Wegovy, Mounjaro, and Zepbound have experienced documented shortages. A discount card cannot guarantee the pharmacy has stock.
  • Cannot combine with Medicare or Medicaid: Federal law prohibits using discount cards alongside government insurance programs. Doing so could constitute fraud.
  • Savings may be smaller than expected: GLP-1 list prices are high. A 10–20% discount still leaves most people paying $700–$1,100 per month.
  • Membership fees: Some programs charge monthly or annual membership fees that reduce net savings.
  • No clinical support: TrumpRx provides no medical guidance on dosing, side effect management, or injection technique.

Frequently Asked Questions

Yes. All GLP-1 medications are prescription-only under federal law. TrumpRx is a pricing tool, not a prescribing service. You must obtain a valid prescription from a licensed clinician before the pharmacy can fill it.
Generally, you cannot use a discount card at the same time as insurance for the same prescription. You would typically choose whichever option is cheaper. If your insurance covers a GLP-1, run both numbers before deciding.
No. Federal law prohibits using third-party discount cards in conjunction with Medicare or Medicaid. Doing so is a federal offense. Beneficiaries should explore their plan's formulary or the manufacturer's patient assistance programs instead.
No. Manufacturer programs — like Novo Nordisk's NovoCare and Eli Lilly's LillyDirect savings cards — are run by the drug makers and often offer steeper discounts for eligible commercially insured patients. TrumpRx is an independent third-party discount network.
No. TrumpRx has no role in clinical management. Your prescriber determines the titration schedule. For reference, FDA labeling for semaglutide and tirzepatide both require a gradual dose escalation over several weeks to minimize gastrointestinal side effects.
Contact other participating pharmacies in the network or ask your prescriber to check alternative pharmacies. Do not skip doses without speaking to your prescriber, as abrupt discontinuation can affect blood sugar control or weight management progress.
Possibly. Both Novo Nordisk and Eli Lilly offer patient assistance programs for uninsured or underinsured patients who meet income criteria. The NIH MedlinePlus semaglutide page links to additional resources. Ask your pharmacist or prescriber about NeedyMeds or the manufacturer's own assistance hotlines.
Discount cards typically apply to commercially manufactured, FDA-approved drug products dispensed at retail pharmacies. Compounded medications are generally prepared by compounding pharmacies under different pricing structures and are unlikely to accept standard discount cards.

If you are navigating GLP-1 costs, bring a list of all savings options — including manufacturer cards, discount programs, and your insurance formulary — to your next appointment. Your prescriber and pharmacist together are the best team to help you identify the most affordable and legally appropriate path for your specific situation.

Sources
  • FDA Ozempic Prescribing Information (semaglutide injection), Novo Nordisk, 2023
  • FDA Wegovy Prescribing Information (semaglutide injection 2.4 mg), Novo Nordisk, 2023
  • FDA Mounjaro Prescribing Information (tirzepatide injection), Eli Lilly, 2023
  • FDA Zepbound Prescribing Information (tirzepatide injection), Eli Lilly, 2023
  • NIH MedlinePlus: Semaglutide Injection, https://medlineplus.gov/druginfo/meds/a622044.html

This site provides general information only and does not constitute medical advice. All content is sourced to FDA labeling, NIH publications, or peer-reviewed clinical trials. Always consult your prescriber before making any medication decision.